BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26820938)

  • 1. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
    Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
    Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Bao-Hongluan ; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Jun; 71(6):345-8. PubMed ID: 27455555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK.
    Tang Q; Xu A; Yang Y; Zhang Y; Sun J
    Discov Med; 2023 Jun; 35(176):208-220. PubMed ID: 37272088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
    Nakashima M; Meirmanov S; Naruke Y; Kondo H; Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Takamura N; Namba H; Ito M; Abrosimov A; Lushnikov E; Roumiantsev P; Tsyb A; Yamashita S; Sekine I
    J Pathol; 2004 Apr; 202(4):446-55. PubMed ID: 15095272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of Pin1 and Cyclin D1 in cervical cancer cell lines and cervical epithelial tissues].
    Li HY; Xu Q; Zhu T; Zhou JH; Deng DR; Wang SX; Lu YP; Ma D
    Ai Zheng; 2006 Mar; 25(3):367-72. PubMed ID: 16536997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl-prolyl isomerase Pin1-mediated abrogation of APC-β-catenin interaction in squamous cell carcinoma of cervix.
    Jawanjal P; Salhan S; Dhawan I; Tripathi R; Rath G
    Rom J Morphol Embryol; 2014; 55(1):83-90. PubMed ID: 24715170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
    Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
    Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
    Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
    Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
    Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
    Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
    Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
    Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2006 Sep; 16(3):505-11. PubMed ID: 16865250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Pin1, beta-catenin and cyclin D1 in salivary adenoid cystic carcinoma and its significance].
    Zhou CX; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Oct; 41(10):623-6. PubMed ID: 17129455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.
    Kruiswijk F; Hasenfuss SC; Sivapatham R; Baar MP; Putavet D; Naipal KA; van den Broek NJ; Kruit W; van der Spek PJ; van Gent DC; Brenkman AB; Campisi J; Burgering BM; Hoeijmakers JH; de Keizer PL
    Oncogene; 2016 Apr; 35(17):2166-77. PubMed ID: 26279295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIN1 expression contributes to hepatic carcinogenesis.
    Pang RW; Lee TK; Man K; Poon RT; Fan ST; Kwong YL; Tse E
    J Pathol; 2006 Sep; 210(1):19-25. PubMed ID: 16841372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.